Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack J Lee

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
RMD Open|September 25, 2020
Comparison of carotid artery ultrasound and Framingham risk score for discriminating coronary artery disease in patients with psoriatic arthritisIsaac T Cheng, Ka Tak Wong, Edmund K Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2016
Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma PatientsEdwin R Parra, Carmen Behrens, Jaime Rodriguez-Canales, et al.
Journal of Autoimmunity|February 6, 2026
Vascular effects of achieving low disease activity in axial spondyloarthritis - A 2-year prospective treat-to-target studyHuan Meng, Sze-Lok Lau, Isaac T Cheng, et al.
Oncotarget|May 10, 2014
Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigmsJennifer J Wheler, Barbara A Parker, Jack J Lee, et al.
Rheumatology (Oxford, England)|February 23, 2020
Treat to target and prevention of subclinical atherosclerosis in psoriatic arthritis-which target should we choose?Isaac T Cheng, Edmund K Li, Priscilla C Wong, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2018
Bone Mass, Microstructure, and Strength Can Discriminate Vertebral Fracture in Patients on Long-Term Steroid TreatmentJiayun Shen, James F Griffith, Tracy Y Zhu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2005
Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lung cancerRoy S Herbst, David H Johnson, Eric Mininberg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 26, 2016
Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysisPierre Blanchard, Adam S Garden, G Brandon Gunn, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 26, 2018
Effect of Achieving Minimal Disease Activity on the Progression of Subclinical Atherosclerosis and Arterial Stiffness: A Prospective Cohort Study in Psoriatic ArthritisIsaac T Cheng, Qing Shang, Edmund K Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2017
The HGF/c-MET Pathway Is a Driver and Biomarker of VEGFR-inhibitor Resistance and Vascular Remodeling in Non-Small Cell Lung CancerTina Cascone, Li Xu, Heather Y Lin, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
RMD Open|September 25, 2020
Comparison of carotid artery ultrasound and Framingham risk score for discriminating coronary artery disease in patients with psoriatic arthritisIsaac T Cheng, Ka Tak Wong, Edmund K Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2016
Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma PatientsEdwin R Parra, Carmen Behrens, Jaime Rodriguez-Canales, et al.
Journal of Autoimmunity|February 6, 2026
Vascular effects of achieving low disease activity in axial spondyloarthritis - A 2-year prospective treat-to-target studyHuan Meng, Sze-Lok Lau, Isaac T Cheng, et al.
Oncotarget|May 10, 2014
Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigmsJennifer J Wheler, Barbara A Parker, Jack J Lee, et al.
Rheumatology (Oxford, England)|February 23, 2020
Treat to target and prevention of subclinical atherosclerosis in psoriatic arthritis-which target should we choose?Isaac T Cheng, Edmund K Li, Priscilla C Wong, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2018
Bone Mass, Microstructure, and Strength Can Discriminate Vertebral Fracture in Patients on Long-Term Steroid TreatmentJiayun Shen, James F Griffith, Tracy Y Zhu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2005
Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lung cancerRoy S Herbst, David H Johnson, Eric Mininberg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 26, 2016
Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysisPierre Blanchard, Adam S Garden, G Brandon Gunn, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 26, 2018
Effect of Achieving Minimal Disease Activity on the Progression of Subclinical Atherosclerosis and Arterial Stiffness: A Prospective Cohort Study in Psoriatic ArthritisIsaac T Cheng, Qing Shang, Edmund K Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2017
The HGF/c-MET Pathway Is a Driver and Biomarker of VEGFR-inhibitor Resistance and Vascular Remodeling in Non-Small Cell Lung CancerTina Cascone, Li Xu, Heather Y Lin, et al.
Pageof 3